Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Crohn's Disease Excellence Forum

Crohn's Disease
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Ed Loftus
Video
Edward Loftus, MD, on the ADVANCE and MOTIVATE Studies of Risankizumab in Crohn Disease
11/11/2011
Dr Loftus, from the Mayo Clinic in Rochester, Minnesota, reviews his Presidental Poster Award-winning presentation on results from the phase 3 ADVANCE and MOTIVATE studies of risankizumab therapy among patients with Crohn disease.
Dr Loftus, from the Mayo Clinic in Rochester, Minnesota, reviews his Presidental Poster Award-winning presentation on results from the phase 3 ADVANCE and MOTIVATE studies of risankizumab therapy among patients with Crohn disease.
Dr Loftus, from the Mayo Clinic...
11/11/2011
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
David Rubin, MD, on the GALAXI 2 and 3 Trials of Guselkumab in Crohn's Disease
11/13/2002
Dr Rubin recaps his presentation from the ACG scientific meeting on the results of phase 3 trials of guselkumab for treatment of Crohn's disease among patients who are bionaive, bioexposed, and biointolerant or who failed to respond to...
Dr Rubin recaps his presentation from the ACG scientific meeting on the results of phase 3 trials of guselkumab for treatment of Crohn's disease among patients who are bionaive, bioexposed, and biointolerant or who failed to respond to...
Dr Rubin recaps his presentation...
11/13/2002
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
Vedolizumab Success Rate Appears Low in Active Perianal Crohn Disease
02/21/2020
Perianal Crohn disease (CD) is persistent, and treating patients is challenging. Authors of a new study sought to assess the effectiveness of vedolizumab in perianal CD and the predictors of success in a real‐life cohort.
Perianal Crohn disease (CD) is persistent, and treating patients is challenging. Authors of a new study sought to assess the effectiveness of vedolizumab in perianal CD and the predictors of success in a real‐life cohort.
Perianal Crohn disease (CD) is...
02/21/2020
Advances in Inflammatory Bowel Disease Network
News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
News
Assessing Transmural Healing and Response in Patients with Crohn's Disease
11/11/2024
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score...
11/11/2024
Advances in Inflammatory Bowel Disease Network
News
MRE or IUS for Crohn’s Disease Imaging?
11/06/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
11/06/2024
Advances in Inflammatory Bowel Disease Network
News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

IBD logo
Podcast
IBD Drive Time: Importance of Diet in the Management of Crohn's Disease
05/25/2023
In the third episode of IBD Drive Time, host Raymond Cross, MD, discusses research into how diet can alleviate symptoms—or worsen disease—among patients with Crohn's disease with Dr James Lewis, who conducted the DINE-CD study.
In the third episode of IBD Drive Time, host Raymond Cross, MD, discusses research into how diet can alleviate symptoms—or worsen disease—among patients with Crohn's disease with Dr James Lewis, who conducted the DINE-CD study.
In the third episode of IBD...
05/25/2023
Advances in Inflammatory Bowel Disease Network
Saurabh Mehandru
Podcast
Saurabh Mehandru, MD, on Durability of Response to p19 Inhibitors in IBD
03/24/2023
Dr. Mehandru reviews the results of 3 pivotal clinical trials on p19 inhibitors where the drug effect was found to be sustained for an extended period following drug withdrawal.
Dr. Mehandru reviews the results of 3 pivotal clinical trials on p19 inhibitors where the drug effect was found to be sustained for an extended period following drug withdrawal.
Dr. Mehandru reviews the results...
03/24/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Sara Horst, MD, on Risankizumab for Crohn Disease
07/12/2022
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive...
07/12/2022
Advances in Inflammatory Bowel Disease Network
Phillip Fleshner
Podcast
Phillip Fleshner, MD, on Perianal/Fistulizing Crohn's Disease
04/30/2022
In this podcast, Dr Phillip Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center in Los Angeles, discusses the complexities of medical and surgical treatment of perianal and fistulizing Crohn disease, which he spoke about...
In this podcast, Dr Phillip Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center in Los Angeles, discusses the complexities of medical and surgical treatment of perianal and fistulizing Crohn disease, which he spoke about...
In this podcast, Dr Phillip...
04/30/2022
Advances in Inflammatory Bowel Disease Network
David Schwartz, MD
Podcasts
David Schwartz, MD, on the ENTERPRISE Study of Vedolizumab for Perianal Crohn Disease
12/30/2021
In this podcast, Dr Schwartz, from Vanderbilt University, discusses the ENTERPRISE multinational program that examined the efficacy and safety of vedolizumab for perianal Crohn’s disease.
In this podcast, Dr Schwartz, from Vanderbilt University, discusses the ENTERPRISE multinational program that examined the efficacy and safety of vedolizumab for perianal Crohn’s disease.
In this podcast, Dr Schwartz,...
12/30/2021
Advances in Inflammatory Bowel Disease Network
Adam Cheifetz
Podcast
Adam Cheifetz, MD, and Konstantinos Papamichail, MD, on Therapeutic Drug Monitoring in Fistulizing Crohn Disease
09/03/2021
In this podcast, Adam Cheifetz, MD, director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School, and Konstantinos Papamichail, M.D., Ph.D., instructor in...
In this podcast, Adam Cheifetz, MD, director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School, and Konstantinos Papamichail, M.D., Ph.D., instructor in...
In this podcast, Adam Cheifetz,...
09/03/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst, MD, and David Schwartz, MD, on Current and Upcoming Treatments for Perianal Crohn Disease
Podcasts
Sara Horst, MD, and David Schwartz, MD, on Current and Upcoming Treatments for Perianal Crohn Disease
05/07/2021
In this podcast, Drs Sara Horst and David Schwartz of Vanderbilt University wrap up their podcast series on perinanal Crohn disease with a discussion of existing and upcoming therapies and procedures.
In this podcast, Drs Sara Horst and David Schwartz of Vanderbilt University wrap up their podcast series on perinanal Crohn disease with a discussion of existing and upcoming therapies and procedures.
In this podcast, Drs Sara Horst...
05/07/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst, MD, and David Schwartz, MD, on Refractory Perianal Crohn's Disease
Podcasts
Sara Horst, MD, and David Schwartz, MD, on Refractory Perianal Crohn's Disease
04/26/2021
Drs Sara Horst and David Schwartz from Vanderbilt University continue their podcast series on Crohn disease in this discussion about the challenges of treating the patient with refractory Crohn disease and their approach to controlling the...
Drs Sara Horst and David Schwartz from Vanderbilt University continue their podcast series on Crohn disease in this discussion about the challenges of treating the patient with refractory Crohn disease and their approach to controlling the...
Drs Sara Horst and David...
04/26/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst, MD and David Schwartz, MD, on Surgery and Therapies for Perianal Crohn Disease
Podcasts
Sara Horst, MD and David Schwartz, MD, on Surgery and Therapies for Perianal Crohn Disease
04/08/2021
In this second podcast of a series on the care of patients with perianal Crohn disease, Dr Horst and Dr Schwartz, both from Vanderbilt University, discuss when to involve a surgeon and the preferred medical therapies used to treat this...
In this second podcast of a series on the care of patients with perianal Crohn disease, Dr Horst and Dr Schwartz, both from Vanderbilt University, discuss when to involve a surgeon and the preferred medical therapies used to treat this...
In this second podcast of a...
04/08/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst, MD, and David Schwartz, MD, on Managing Patient Expectations in Treating Crohn Disease
Podcasts
Sara Horst, MD, and David Schwartz, MD, on Managing Patient Expectations in Treating Crohn Disease
03/26/2021
In part 1 of a 5-part series on the challenges of treating perianal Crohn disease, Sara Horst, MD, and David Schwartz, MD, from Vanderbilt University Medical Center, discuss how to manage patient expectations concerning treatment and outcomes.
In part 1 of a 5-part series on the challenges of treating perianal Crohn disease, Sara Horst, MD, and David Schwartz, MD, from Vanderbilt University Medical Center, discuss how to manage patient expectations concerning treatment and outcomes.
In part 1 of a 5-part series on...
03/26/2021
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement